Indeed, KRAS-driven lung cancer has a greater resistance to ferroptosis owing to a reprogrammed lipid metabolism by a higher level of acyl-coenzyme A synthetase long-chain family member 3 (ACSL3) expression [16]. The gene discussed is ACSL3; the disease is lung cancer.